Review of New Biological Drugs and JAK Inhibitors Approved for Children and Adolescents With Moderate to Severe Atopic Dermatitis: The Situation in Uruguay. Arch Pediatr Urug 2026, 97 (1), e801. https://doi.org/10.31134/AP.97.1.20.